Glaxo starting late-stage study of asthma drug

Posted: 10/29/2012

British drugmaker GlaxoSmithKline PLC said Monday that it is starting two late-stage patient studies of an experimental biologic drug as an add-on treatment for patients with severe, uncontrolled asthma.

Both studies will compare the safety and effectiveness of mepolizumab, an antibody-based drug produced in living cells, to a placebo treatment. Read more.